{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:51:34Z","timestamp":1791445894482,"version":"4.3.3"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jinf.2016.05.008","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T00:09:45Z","timestamp":1465258185000},"page":"241-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013"],"prefix":"10.1016","volume":"73","author":[{"given":"Peter H.F.","family":"Hobbelen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Stowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayatri","family":"Amirthalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert-Jan","family":"van Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2016.05.008_bib1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1017\/S0950268804003140","article-title":"Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults","volume":"132","author":"Vyse","year":"2004","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2016.05.008_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/archdischild-2015-308283","article-title":"Varicella paediatric hospitalisations in Belgium: a 1-year national survey","volume":"101","author":"Blumental","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jinf.2016.05.008_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2334-12-110","article-title":"Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands","volume":"12","author":"Pierik","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2016.05.008_bib4","unstructured":"Joint Committee on Vaccination and Immunisation. Joint Committee on Vaccination and Immunisation Statement on varicella and herpes zoster vaccines 2013. Available from: http:\/\/webarchive.nationalarchives.gov.uk\/20120907090205\/http:\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/@dh\/@ab\/documents\/digitalasset\/dh_133599.pdf."},{"key":"10.1016\/j.jinf.2016.05.008_bib5","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.vaccine.2008.12.024","article-title":"Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales","volume":"27","author":"van Hoek","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.05.008_bib6","doi-asserted-by":"crossref","first-page":"e66485","DOI":"10.1371\/journal.pone.0066485","article-title":"Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review","volume":"8","author":"Ogunjimi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2016.05.008_bib7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study","volume":"360","author":"Thomas","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2016.05.008_bib8","unstructured":"Public Health England. Shingles vaccine coverage report, England, September 2014 to February 2015. Infection report: volume 9, number 14. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/424007\/hpr1415_shngls_vc.pdf."},{"key":"10.1016\/j.jinf.2016.05.008_bib9","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1542\/peds.2008-0567","article-title":"Varicella prevention in the United States: a review of successes and challenges","volume":"122","author":"Marin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jinf.2016.05.008_bib10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1542\/peds.2010-3385","article-title":"Near elimination of varicella deaths in the US after implementation of the vaccination program","volume":"128","author":"Marin","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jinf.2016.05.008_bib11","series-title":"The UK private health market","author":"The King's Fund","year":"2014"},{"key":"10.1016\/j.jinf.2016.05.008_bib12","unstructured":"World Health Organization. International statistical classification of diseases and related health problems 10th revision. Available from: http:\/\/apps.who.int\/classifications\/icd10\/browse\/2015\/en."},{"key":"10.1016\/j.jinf.2016.05.008_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","article-title":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England","volume":"65","author":"van Hoek","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2016.05.008_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.jinf.2016.05.008_bib15","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","article-title":"New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality","volume":"57","author":"Sundararajan","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jinf.2016.05.008_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","article-title":"How to measure comorbidity: a critical review of available methods","volume":"56","author":"de Groot","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jinf.2016.05.008_bib17","unstructured":"Office for National Statistics. Population estimates for England and Wales, mid-2002 to mid-2010 revised (national). Available from: http:\/\/www.ons.gov.uk\/ons\/publications\/re-reference-tables.html?edition=tcm%3A77-269171."},{"key":"10.1016\/j.jinf.2016.05.008_bib18","unstructured":"Office for National Statistics. Annual mid-year population estimates, 2011 and 2012. Available from: http:\/\/www.ons.gov.uk\/ons\/rel\/pop-estimate\/population-estimates-for-uk\u2013england-and-wales\u2013scotland-and-northern-ireland\/mid-2011-and-mid-2012\/stb\u2013-mid-2011\u2013-mid-2012-uk-population-estimates.html."},{"key":"10.1016\/j.jinf.2016.05.008_bib19","unstructured":"Office for National Statistics. National life tables, England, 1980\u20131982 to 2012\u20132014. Available from: http:\/\/www.ons.gov.uk\/ons\/taxonomy\/index.html?nscl=Life+Tables#tab-data-tables."},{"key":"10.1016\/j.jinf.2016.05.008_bib20","unstructured":"Department of Health. Payment by results step-by-step guide: calculating the 2013\u201314 national tariff. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/214905\/Step-by-step-guide-to-calculating-the-2013-14-national-tariff.pdf."},{"key":"10.1016\/j.jinf.2016.05.008_bib21","unstructured":"Department of Health. PbR tariff information spreadsheet for 2013 to 2014. Available from: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/210979\/07_-_Tariff_information_spreadsheet_2013-14_v6.xls."},{"key":"10.1016\/j.jinf.2016.05.008_bib22","unstructured":"Department of Health. NHS reference costs 2013 to 2014. Available from: https:\/\/www.gov.uk\/government\/publications\/nhs-reference-costs-2013-to-2014."},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2016.05.008_bib23","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1002\/jmv.10313","article-title":"Epidemiology of varicella-zoster virus in England and Wales","volume":"70","author":"Brisson","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.jinf.2016.05.008_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2054270414562984","article-title":"Trends in hospital admissions for varicella and zoster viruses in England, 2001\/2002-2010\/2011: time trend study","volume":"6","author":"Abdalrahman","year":"2015","journal-title":"JRSM Open"},{"key":"10.1016\/j.jinf.2016.05.008_bib25","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1017\/S0950268811002640","article-title":"The health and economic burden of chickenpox and herpes zoster in Belgium","volume":"140","author":"Bilcke","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2016.05.008_bib26","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.vaccine.2006.02.017","article-title":"The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination","volume":"24","author":"de Melker","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.05.008_bib27","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.vaccine.2004.04.004","article-title":"Epidemiology of severe varicella-zoster virus infection in Spain","volume":"22","author":"Gil","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.05.008_bib28","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.vaccine.2010.01.036","article-title":"A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria","volume":"28","author":"Carville","year":"2010","journal-title":"Australia Vaccine"},{"key":"10.1016\/j.jinf.2016.05.008_bib29","first-page":"1","article-title":"The burden of varicella and zoster in British Columbia 1994-2003: baseline assessment prior to universal vaccination","volume":"33","author":"Edgar","year":"2007","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.jinf.2016.05.008_bib30","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1016\/j.vaccine.2007.07.049","article-title":"Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination","volume":"25","author":"Di Legami","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.05.008_bib31","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1016\/j.vaccine.2010.09.074","article-title":"Herpes zoster: burden of disease in France","volume":"28","author":"Gonzalez","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.05.008_bib32","first-page":"13","article-title":"Disease burden of herpes zoster in Sweden\u2013predominance in the elderly and in women - a register based study","author":"Studahl","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2016.05.008_bib33","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1016\/j.vaccine.2011.09.024","article-title":"Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program","volume":"29","author":"Tanuseputro","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.05.008_bib34","first-page":"13","article-title":"Herpes zoster surveillance using electronic databases in the Valencian community (Spain)","author":"Morant-Talamante","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2016.05.008_bib35","first-page":"11","article-title":"Herpes zoster in Germany: quantifying the burden of disease","author":"Ultsch","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2016.05.008_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268803001523","article-title":"Gender difference in the incidence of shingles","volume":"132","author":"Fleming","year":"2004","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2016.05.008_bib37","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.vaccine.2011.01.037","article-title":"Modelling the impact of a combined varicella and zoster vaccination\u00a0programme on the epidemiology of varicella zoster\u00a0virus in England","volume":"29","author":"van Hoek","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.05.008_bib38","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","article-title":"The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group","volume":"325","author":"Hardy","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2016.05.008_bib39","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2016.05.008_bib40","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1086\/591132","article-title":"Hospitalizations to treat herpes zoster in older adults: causes and validated rates","volume":"47","author":"Jackson","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.05.008_bib41","first-page":"15","article-title":"Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France","author":"Blein","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2016.05.008_bib42","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jpeds.2014.06.014","article-title":"Central nervous system complications of varicella-zoster virus","volume":"165","author":"Science","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.jinf.2016.05.008_bib43","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1469-0691.2011.03705.x","article-title":"Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients","volume":"18","author":"De Broucker","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2016.05.008_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcv.2009.07.014","article-title":"Varicella-zoster virus CNS disease\u2014viral load, clinical manifestations and sequels","volume":"46","author":"Persson","year":"2009","journal-title":"J Clin Virol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316300937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316300937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:24:12Z","timestamp":1759008252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445316300937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0163445316300937"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2016.05.008","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2016.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ltd on behalf of The British Infection Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}